Data / Form D filings / Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc.: Form D filings
Immunomic Therapeutics, Inc., a biotechnology company in Rockville, MD, filed 13 Form D notices with the SEC between 2012 and 2025. The latest, on June 2, 2025, reports $6.5 million sold of a $16 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ATTN: Erin Duffy, 15010 BROSCHART RD., SUITE 250, Rockville, MD, 20850
- Phone
- (301) 968-3509
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1543256
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2025 | New notice | $16,000,000 | $6,500,000 | $9,500,000 | 1 | May 29, 2025 | sec.gov |
| Apr 10, 2024 | New notice | $20,900,000 | $3,000,000 | $17,900,000 | 1 | Jan 30, 2024 | sec.gov |
| Jan 14, 2021 | Amendment | $77,728,230 | $77,728,230 | 6 | Feb 18, 2020 | sec.gov | |
| Feb 26, 2020 | New notice | $60,000,000 | $10,000,000 | $50,000,000 | 1 | Feb 18, 2020 | sec.gov |
| Aug 3, 2018 | New notice | $314,500 | $314,500 | 1 | Jul 18, 2018 | sec.gov | |
| Mar 15, 2017 | New notice | $10,000,000 | $4,629,750 | $5,370,250 | 47 | Feb 28, 2017 | sec.gov |
| Oct 15, 2014 | Amendment | $8,800,000 | $6,755,052 | $2,044,948 | 56 | Dec 28, 2013 | sec.gov |
| Oct 15, 2014 | Amendment | $8,800,000 | $6,755,052 | $2,044,948 | 56 | Dec 28, 2013 | sec.gov |
| Apr 24, 2014 | New notice | $8,800,000 | $1,029,000 | $7,771,000 | 10 | Apr 24, 2014 | sec.gov |
| Jun 12, 2013 | New notice | $3,000,000 | $2,729,500 | $270,500 | 36 | Jun 12, 2013 | sec.gov |
| Jun 12, 2013 | New notice | $1,300,000 | $1,117,500 | $182,500 | 30 | Oct 31, 2012 | sec.gov |
| Jun 12, 2013 | Amendment | $2,000,000 | $1,617,000 | $383,000 | 60 | Aug 16, 2011 | sec.gov |
| Mar 5, 2012 | New notice | $2,000,000 | $1,101,260 | $898,740 | 7 | Aug 16, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Yang Gon Jin | Director | |
| Steve Park | Director | |
| Robert Ahlgren | Director | |
| Dong-Gun Kim | Executive Officer, Director | |
| James Wishart | Director | |
| Ki-Hong Ahn | Director | |
| Matthew Chang | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Jun 2, 2025 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Immunomic Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.